Total Payments
$1,252
2024 Payments
$377.09
Companies
19
Transactions
62
Medicare Patients
3,479
Medicare Billing
$197,843
Payment Breakdown by Category
Food & Beverage$1,252 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,252 | 62 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $177.66 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $125.29 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $124.02 | 5 | $0 (2024) |
| Novo Nordisk Inc | $120.51 | 6 | $0 (2023) |
| Amarin Pharma Inc. | $112.77 | 5 | $0 (2021) |
| Lilly USA, LLC | $83.77 | 5 | $0 (2024) |
| ABBVIE INC. | $80.06 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $68.90 | 3 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $51.85 | 3 | $0 (2023) |
| ITI, Inc. | $48.80 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $377.09 | 17 | Astellas Pharma US Inc ($77.71) |
| 2023 | $409.41 | 20 | AstraZeneca Pharmaceuticals LP ($78.08) |
| 2022 | $82.37 | 5 | AstraZeneca Pharmaceuticals LP ($32.70) |
| 2021 | $382.84 | 20 | GlaxoSmithKline, LLC. ($117.29) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $31.42 | General |
| Category: Biological | ||||||
| 11/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: DIABETES | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: PAIN | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: PSYCHIATRY | ||||||
| 07/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: NEUROSCIENCE | ||||||
| 05/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), TRADJENTA, JARDIANCE | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: DIABETES | ||||||
| 05/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: RESPIRATORY | ||||||
| 02/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Biological | ||||||
| 02/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Diabetes Care | ||||||
| 02/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: PSYCHIATRY | ||||||
| 01/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON, VIBERZI | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/10/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: ANTI-ANXIETY | ||||||
| 01/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Biological | ||||||
| 12/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Gastroenterology | ||||||
| 12/04/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: PSYCHIATRY | ||||||
| 12/01/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: PSYCHIATRY | ||||||
| 11/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Respiratory | ||||||
| 11/27/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Diabetes | ||||||
| 11/08/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 611 | 908 | $196,735 | $35,869 |
| 2022 | 15 | 1,328 | 1,855 | $320,930 | $67,430 |
| 2021 | 14 | 1,142 | 1,537 | $303,038 | $68,914 |
| 2020 | 9 | 398 | 554 | $141,745 | $25,630 |
Total Patients
3,479
Total Services
4,854
Medicare Billing
$197,843
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 256 | $78,026 | $13,126 | 16.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 91 | 166 | $67,230 | $10,127 | 15.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 158 | $32,548 | $7,821 | 24.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $5,082 | $1,622 | 31.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 108 | 125 | $8,375 | $1,088 | 13.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 15 | $2,445 | $1,079 | 44.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $1,095 | $487.50 | 44.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 84 | 94 | $846.00 | $313.72 | 37.1% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 44 | 68 | $1,088 | $205.00 | 18.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 132 | 230 | $93,150 | $17,769 | 19.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 145 | 145 | $51,651 | $16,933 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 270 | $82,080 | $12,341 | 15.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 96 | 143 | $29,458 | $5,394 | 18.3% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 20 | 22 | $10,208 | $3,384 | 33.2% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 36 | 36 | $5,868 | $2,392 | 40.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 39 | 47 | $14,288 | $1,799 | 12.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 127 | 154 | $10,318 | $1,354 | 13.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 70 | 70 | $3,570 | $1,166 | 32.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 35 | $2,555 | $1,114 | 43.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 24 | 31 | $6,386 | $993.18 | 15.6% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 135 | 240 | $3,840 | $879.79 | 22.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 147 | 240 | $1,920 | $705.42 | 36.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 36 | 46 | $4,324 | $703.70 | 16.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 131 | 146 | $1,314 | $501.10 | 38.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 172 | 372 | $113,088 | $21,754 | 19.2% |
About Cameron Campbell
Cameron Campbell is a Primary Care healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2015. The National Provider Identifier (NPI) number assigned to this provider is 1497149348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cameron Campbell has received a total of $1,252 in payments from pharmaceutical and medical device companies, with $377.09 received in 2024. These payments were reported across 62 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,252).
As a Medicare-enrolled provider, Campbell has provided services to 3,479 Medicare beneficiaries, totaling 4,854 services with total Medicare billing of $197,843. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Location Baltimore, MD
- Active Since 03/27/2015
- Last Updated 03/27/2015
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1497149348
Products in Payments
- TRELEGY ELLIPTA (Drug) $135.16
- Veozah (Drug) $124.02
- Vascepa (Drug) $112.77
- Ozempic (Drug) $98.27
- CAPLYTA (Drug) $96.94
- TRINTELLIX (Drug) $68.90
- MOUNJARO (Drug) $65.96
- BREZTRI (Drug) $63.59
- FARXIGA (Drug) $61.70
- XIFAXAN (Drug) $51.85
- REXULTI (Drug) $48.42
- LINZESS (Drug) $43.52
- ANORO ELLIPTA (Drug) $42.50
- VIBERZI (Drug) $36.54
- LOREEV XR (Drug) $26.83
- SYNJARDY (Drug) $24.63
- Rybelsus (Drug) $22.24
- NURTEC ODT (Drug) $20.54
- Cologuard Collection Kit (Device) $18.93
- TRULICITY (Drug) $17.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Baltimore
Mrs. Ashley Salamone, Crnp, CRNP
Primary Care — Payments: $12,430
Primary Care $12,430
Ololade Ikuomola, Np-C, NP-C
Primary Care — Payments: $8,601
Primary Care $8,601
Yury Malachevsky, Crnp, CRNP
Primary Care — Payments: $5,375
Primary Care $5,375
Mary Weber, Crnp, CRNP
Primary Care — Payments: $2,608
Primary Care $2,608
Xiaohong Jiang
Primary Care — Payments: $2,338
Primary Care $2,338
Valerie Peterson, Crnp, CRNP
Primary Care — Payments: $1,276
Primary Care $1,276